The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Malignant Ascites Treatment Market Research Report 2024
Synopsis
The most common malignancies associated with the development of ascites include cancers of the colon/rectum, ovary, breast, lung, pancreas, liver and lymphoma. Treatment strategies include paracentesis, diuretics and peritoneovenous shunts and so on.
The global Malignant Ascites Treatment market was valued at US$ 484 million in 2023 and is anticipated to reach US$ 674.6 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
Global Malignant Ascites Treatment key players include BD, B. Braun, Pfizer, Merit Medical Systems, Pfm Medical Ag, etc. Global top five manufacturers hold a share about 40%. North America is the largest market, with a share about 30%, followed by Europe and Middle East & Africa, both have a share about 60 percent. In terms of product, Paracentesis is the largest segment, with a share over 65%.
This report aims to provide a comprehensive presentation of the global market for Malignant Ascites Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Malignant Ascites Treatment.
Report Scope
The Malignant Ascites Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Malignant Ascites Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Malignant Ascites Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Pfizer
B. Braun
Merit Medical Systems
Pfm Medical Ag
Medtronic
CMP Pharma
GI Supply (Laborie Medical Technologies)
The Surgical Company Group
Sequana Medical
PharmaCyte Biotech
BioVie
Clover Biopharmaceuticals
Segment by Type
Paracentesis
Chemotherapy
Surgical Treatment
Others
Segment by Application
Hospitals
Clinics
Homecare
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Malignant Ascites Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The most common malignancies associated with the development of ascites include cancers of the colon/rectum, ovary, breast, lung, pancreas, liver and lymphoma. Treatment strategies include paracentesis, diuretics and peritoneovenous shunts and so on.
The global Malignant Ascites Treatment market was valued at US$ 484 million in 2023 and is anticipated to reach US$ 674.6 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
Global Malignant Ascites Treatment key players include BD, B. Braun, Pfizer, Merit Medical Systems, Pfm Medical Ag, etc. Global top five manufacturers hold a share about 40%. North America is the largest market, with a share about 30%, followed by Europe and Middle East & Africa, both have a share about 60 percent. In terms of product, Paracentesis is the largest segment, with a share over 65%.
This report aims to provide a comprehensive presentation of the global market for Malignant Ascites Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Malignant Ascites Treatment.
Report Scope
The Malignant Ascites Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Malignant Ascites Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Malignant Ascites Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Pfizer
B. Braun
Merit Medical Systems
Pfm Medical Ag
Medtronic
CMP Pharma
GI Supply (Laborie Medical Technologies)
The Surgical Company Group
Sequana Medical
PharmaCyte Biotech
BioVie
Clover Biopharmaceuticals
Segment by Type
Paracentesis
Chemotherapy
Surgical Treatment
Others
Segment by Application
Hospitals
Clinics
Homecare
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Malignant Ascites Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Malignant Ascites Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Paracentesis
1.2.3 Chemotherapy
1.2.4 Surgical Treatment
1.2.5 Others
1.3 Market by Application
1.3.1 Global Malignant Ascites Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Malignant Ascites Treatment Market Perspective (2019-2030)
2.2 Malignant Ascites Treatment Growth Trends by Region
2.2.1 Global Malignant Ascites Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Malignant Ascites Treatment Historic Market Size by Region (2019-2024)
2.2.3 Malignant Ascites Treatment Forecasted Market Size by Region (2025-2030)
2.3 Malignant Ascites Treatment Market Dynamics
2.3.1 Malignant Ascites Treatment Industry Trends
2.3.2 Malignant Ascites Treatment Market Drivers
2.3.3 Malignant Ascites Treatment Market Challenges
2.3.4 Malignant Ascites Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Malignant Ascites Treatment Players by Revenue
3.1.1 Global Top Malignant Ascites Treatment Players by Revenue (2019-2024)
3.1.2 Global Malignant Ascites Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Malignant Ascites Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Malignant Ascites Treatment Revenue
3.4 Global Malignant Ascites Treatment Market Concentration Ratio
3.4.1 Global Malignant Ascites Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Malignant Ascites Treatment Revenue in 2023
3.5 Malignant Ascites Treatment Key Players Head office and Area Served
3.6 Key Players Malignant Ascites Treatment Product Solution and Service
3.7 Date of Enter into Malignant Ascites Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Malignant Ascites Treatment Breakdown Data by Type
4.1 Global Malignant Ascites Treatment Historic Market Size by Type (2019-2024)
4.2 Global Malignant Ascites Treatment Forecasted Market Size by Type (2025-2030)
5 Malignant Ascites Treatment Breakdown Data by Application
5.1 Global Malignant Ascites Treatment Historic Market Size by Application (2019-2024)
5.2 Global Malignant Ascites Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Malignant Ascites Treatment Market Size (2019-2030)
6.2 North America Malignant Ascites Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Malignant Ascites Treatment Market Size by Country (2019-2024)
6.4 North America Malignant Ascites Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Malignant Ascites Treatment Market Size (2019-2030)
7.2 Europe Malignant Ascites Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Malignant Ascites Treatment Market Size by Country (2019-2024)
7.4 Europe Malignant Ascites Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Malignant Ascites Treatment Market Size (2019-2030)
8.2 Asia-Pacific Malignant Ascites Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Malignant Ascites Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Malignant Ascites Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Malignant Ascites Treatment Market Size (2019-2030)
9.2 Latin America Malignant Ascites Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Malignant Ascites Treatment Market Size by Country (2019-2024)
9.4 Latin America Malignant Ascites Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Malignant Ascites Treatment Market Size (2019-2030)
10.2 Middle East & Africa Malignant Ascites Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Malignant Ascites Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Malignant Ascites Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Malignant Ascites Treatment Introduction
11.1.4 BD Revenue in Malignant Ascites Treatment Business (2019-2024)
11.1.5 BD Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Malignant Ascites Treatment Introduction
11.2.4 Pfizer Revenue in Malignant Ascites Treatment Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 B. Braun
11.3.1 B. Braun Company Detail
11.3.2 B. Braun Business Overview
11.3.3 B. Braun Malignant Ascites Treatment Introduction
11.3.4 B. Braun Revenue in Malignant Ascites Treatment Business (2019-2024)
11.3.5 B. Braun Recent Development
11.4 Merit Medical Systems
11.4.1 Merit Medical Systems Company Detail
11.4.2 Merit Medical Systems Business Overview
11.4.3 Merit Medical Systems Malignant Ascites Treatment Introduction
11.4.4 Merit Medical Systems Revenue in Malignant Ascites Treatment Business (2019-2024)
11.4.5 Merit Medical Systems Recent Development
11.5 Pfm Medical Ag
11.5.1 Pfm Medical Ag Company Detail
11.5.2 Pfm Medical Ag Business Overview
11.5.3 Pfm Medical Ag Malignant Ascites Treatment Introduction
11.5.4 Pfm Medical Ag Revenue in Malignant Ascites Treatment Business (2019-2024)
11.5.5 Pfm Medical Ag Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Malignant Ascites Treatment Introduction
11.6.4 Medtronic Revenue in Malignant Ascites Treatment Business (2019-2024)
11.6.5 Medtronic Recent Development
11.7 CMP Pharma
11.7.1 CMP Pharma Company Detail
11.7.2 CMP Pharma Business Overview
11.7.3 CMP Pharma Malignant Ascites Treatment Introduction
11.7.4 CMP Pharma Revenue in Malignant Ascites Treatment Business (2019-2024)
11.7.5 CMP Pharma Recent Development
11.8 GI Supply (Laborie Medical Technologies)
11.8.1 GI Supply (Laborie Medical Technologies) Company Detail
11.8.2 GI Supply (Laborie Medical Technologies) Business Overview
11.8.3 GI Supply (Laborie Medical Technologies) Malignant Ascites Treatment Introduction
11.8.4 GI Supply (Laborie Medical Technologies) Revenue in Malignant Ascites Treatment Business (2019-2024)
11.8.5 GI Supply (Laborie Medical Technologies) Recent Development
11.9 The Surgical Company Group
11.9.1 The Surgical Company Group Company Detail
11.9.2 The Surgical Company Group Business Overview
11.9.3 The Surgical Company Group Malignant Ascites Treatment Introduction
11.9.4 The Surgical Company Group Revenue in Malignant Ascites Treatment Business (2019-2024)
11.9.5 The Surgical Company Group Recent Development
11.10 Sequana Medical
11.10.1 Sequana Medical Company Detail
11.10.2 Sequana Medical Business Overview
11.10.3 Sequana Medical Malignant Ascites Treatment Introduction
11.10.4 Sequana Medical Revenue in Malignant Ascites Treatment Business (2019-2024)
11.10.5 Sequana Medical Recent Development
11.11 PharmaCyte Biotech
11.11.1 PharmaCyte Biotech Company Detail
11.11.2 PharmaCyte Biotech Business Overview
11.11.3 PharmaCyte Biotech Malignant Ascites Treatment Introduction
11.11.4 PharmaCyte Biotech Revenue in Malignant Ascites Treatment Business (2019-2024)
11.11.5 PharmaCyte Biotech Recent Development
11.12 BioVie
11.12.1 BioVie Company Detail
11.12.2 BioVie Business Overview
11.12.3 BioVie Malignant Ascites Treatment Introduction
11.12.4 BioVie Revenue in Malignant Ascites Treatment Business (2019-2024)
11.12.5 BioVie Recent Development
11.13 Clover Biopharmaceuticals
11.13.1 Clover Biopharmaceuticals Company Detail
11.13.2 Clover Biopharmaceuticals Business Overview
11.13.3 Clover Biopharmaceuticals Malignant Ascites Treatment Introduction
11.13.4 Clover Biopharmaceuticals Revenue in Malignant Ascites Treatment Business (2019-2024)
11.13.5 Clover Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
